Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (1): 92-94.DOI: 10.3969/j.issn.1673-8640.2021.01.019
Previous Articles Next Articles
Received:2019-10-22
Online:2021-01-30
Published:2021-02-05
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.01.019
| 感染部位 | 例数/例 | 百分比/% |
|---|---|---|
| 肺部 | 17 | 48.57 |
| 尿路 | 10 | 28.57 |
| 切口浅层 | 5 | 14.27 |
| 椎间隙 | 3 | 8.58 |
| 感染部位 | 例数/例 | 百分比/% |
|---|---|---|
| 肺部 | 17 | 48.57 |
| 尿路 | 10 | 28.57 |
| 切口浅层 | 5 | 14.27 |
| 椎间隙 | 3 | 8.58 |
| 菌株名称 | 菌株数/株 | 百分比/% |
|---|---|---|
| 革兰阳性菌 | 17 | 44.74 |
| 金黄色葡萄球菌 | 8 | 21.05 |
| 表皮葡萄球菌 | 6 | 15.79 |
| 溶血性葡萄球菌 | 3 | 7.90 |
| 革兰阴性菌 | 20 | 52.63 |
| 大肠埃希菌 | 11 | 28.95 |
| 铜绿假单胞菌 | 6 | 15.79 |
| 鲍曼不动杆菌 | 2 | 5.26 |
| 阴沟肠杆菌 | 1 | 2.63 |
| 真菌 | 1 | 2.63 |
| 白念珠菌 | 1 | 2.63 |
| 合计 | 38 | 100 |
| 菌株名称 | 菌株数/株 | 百分比/% |
|---|---|---|
| 革兰阳性菌 | 17 | 44.74 |
| 金黄色葡萄球菌 | 8 | 21.05 |
| 表皮葡萄球菌 | 6 | 15.79 |
| 溶血性葡萄球菌 | 3 | 7.90 |
| 革兰阴性菌 | 20 | 52.63 |
| 大肠埃希菌 | 11 | 28.95 |
| 铜绿假单胞菌 | 6 | 15.79 |
| 鲍曼不动杆菌 | 2 | 5.26 |
| 阴沟肠杆菌 | 1 | 2.63 |
| 真菌 | 1 | 2.63 |
| 白念珠菌 | 1 | 2.63 |
| 合计 | 38 | 100 |
| 组别 | 例数 | NLR | DD/ （ng/mL） | PLR |
|---|---|---|---|---|
| 感染组 | 35 | 4.33±1.03 | 528.17±43.60 | 126.88±41.76 |
| 非感染组 | 325 | 1.89±0.47 | 317.44±40.89 | 189.03±35.04 |
| t值 | 25.013 | 28.782 | 9.777 | |
| P值 | 0.000 | 0.000 | 0.000 |
| 组别 | 例数 | NLR | DD/ （ng/mL） | PLR |
|---|---|---|---|---|
| 感染组 | 35 | 4.33±1.03 | 528.17±43.60 | 126.88±41.76 |
| 非感染组 | 325 | 1.89±0.47 | 317.44±40.89 | 189.03±35.04 |
| t值 | 25.013 | 28.782 | 9.777 | |
| P值 | 0.000 | 0.000 | 0.000 |
| 组别 | 例数 | IL-35/ （pg/mL） | IL-10/ （μg/L） | PCT/ （μg/L） |
|---|---|---|---|---|
| 感染组 | 35 | 41.69±10.47 | 12.10±3.68 | 4.79±0.40 |
| 非感染组 | 325 | 78.10±10.88 | 31.14±7.26 | 0.36±0.11 |
| t值 | 18.878 | 15.291 | 154.001 | |
| P值 | 0.000 | 0.000 | 0.000 |
| 组别 | 例数 | IL-35/ （pg/mL） | IL-10/ （μg/L） | PCT/ （μg/L） |
|---|---|---|---|---|
| 感染组 | 35 | 41.69±10.47 | 12.10±3.68 | 4.79±0.40 |
| 非感染组 | 325 | 78.10±10.88 | 31.14±7.26 | 0.36±0.11 |
| t值 | 18.878 | 15.291 | 154.001 | |
| P值 | 0.000 | 0.000 | 0.000 |
| [1] | LEE J S,PARK Y M,HA K Y,et al.Preoperative anxiety about spinal surgery under general anesthesia[J]. Eur Spine J,2016,25(3):698-707. |
| [2] | LIU S,QI Q,CHEN Z,et al.Polymicrobial and monomicrobial infections after spinal surgery:a retrospective sudy to determine which infection is more severe[J]. Asian Spine J,2017,11(3):427-436. |
| [3] | 王朝君,冯艳红,张晓丽,等. 不同时间使用抗菌药物与脊椎术后感染临床相关性分析[J]. 中华医院感染学杂志,2016,26(20):4672-4674. |
| [4] | 中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志,2001,81(5):314-320. |
| [5] | KATO S,CHIKUDA H,OHYA J,et al.Risk of infectious complications associated with blood transfusion in elective spinal surgery-a propensity score matched analysis[J]. Spine J,2016,16(1):55-60. |
| [6] | WON Y I,KIM C H,CHUNG C K,et al.The use fibrin sealant after spinal intradural tumor surgery:is it necessary?[J]. Korean J Spine,2016,13(1):24-29. |
| [7] | ZHANG L M,REN L,ZHAO Z Q,et al.Surgical treatment for bacterial meningitis after spinal surgery:a case report[J]. Medicine(Baltimore),2017,96(11):e6099. |
| [8] | FAWI H M T,SABA K,CUNNINGHAM A,et al. Venous thromboembolism in adult elective spinal surgery:a tertiary centre review of 2 181 patients[J]. Bone Joint J,2017,99-B(9):1204-1209. |
| [9] | 刘少强,齐强,陈仲强,等. 临床诊断与病原确诊脊柱术后感染的临床特征对比[J]. 中国矫形外科杂志,2016,24(11):1006-1009. |
| [10] | 赵卫卫,肖林林,刘秀芬,等. 术前外周血中性粒细胞/淋巴细胞比值在乳腺癌诊断中的作用[J]. 检验医学,2018,33(3):209-212. |
| [11] | KOAKUTSU T,SATO T,AIZAWA T,et al.Postoperative changes in presepsin level and values predictive of surgical site infection after spinal surgery:a single center,prospective observational study[J]. Spine(Phila Pa 1976),2018,43(8):578-584. |
| [12] | TUREL M K,KEROLUS M,DEUTSCH H.The role of minimally invasive spine surgery in the management of pyogenic spinal discitis[J]. J Craniovertebr Junction Spine,2017,8(1):39-43. |
| [13] | SMITH T J,BAUER A T,KALLIES K J,et al.Outcomes of anterior exposure for spinal surgery at an independent academic medical center[J]. WMJ,2017,116(1):15-21. |
| [14] | 徐翔,何庆文,肖才文. IL-35抑制炎症反应和T细胞反应性减轻变应性鼻炎的机制研究[J]. 中国免疫学杂志,2017,33(9):1386-1391. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
